White label ELPA - ClinicalTrials.eu

Study of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study of Avapritinib for Adults with Systemic Mastocytosis Who Previously Participated in an Avapritinib Study

Recruiting

3 1 1
Investigated diseases:
- Systemic mastocytosis
Investigated drugs:
- Avapritinib
Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Recruiting

3 1
Investigated diseases:
- Clostridium difficile infection
Investigated drugs:
+8
Study of Lenvatinib for Patients with Poor-Prognosis Hepatocellular Carcinoma Undergoing Percutaneous Ablation Therapy

Recruiting

2 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
- Lenvatinib
Study on Low Oxygen and Nitrous Oxide Use During Anesthesia for Surgery Patients

Recruiting

3 1 1 1
Investigated drugs:
- Nitrous Oxide
- Oxygen
Study on the Effects of Landiolol Hydrochloride for Patients with Microcirculatory Issues During Septic Shock

Recruiting

3 1 1 1
Investigated drugs:
- Landiolol Hydrochloride
Study on Pembrolizumab and Chemotherapy with Radiation for Advanced Non-Small Cell Lung Cancer Patients

Recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Study on Immunotherapy with Nivolumab and Ipilimumab for Patients with Recurrent Head and Neck Cancer After Surgery

Recruiting

2 1 1 1
Investigated diseases:
- Head and neck cancer
Investigated drugs:
- Ipilimumab
- Nivolumab
Study of Carboplatin, Paclitaxel, and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer After Pembrolizumab Treatment Failure

Recruiting

2 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
Study on the Effects of Dendritic Cell Immunotherapy and Temozolomide in Patients with Glioblastoma

Recruiting

4 1 1
Investigated diseases:
- Glioblastoma multiforme
- Glioblastoma
Investigated drugs:
- Temozolomide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies